Castillo-Regalado Edgar, Uchima Hugo
Endoscopy Unit, Department of Gastroenterology, Hospital Universitari Germans Trias i Pujol, Barcelona 08916, Spain.
World J Gastrointest Endosc. 2022 Mar 16;14(3):113-128. doi: 10.4253/wjge.v14.i3.113.
Due to the advent of the screening programs for colorectal cancer and the era of quality assurance colonoscopy the number the polyps that can be considered difficult, including large (> 20 mm) laterally spreading tumors (LSTs), has increased in the last decade. All LSTs should be assessed carefully, looking for suspicious areas of submucosal invasion (SMI), such as nodules or depressed areas, describing the morphology according to the Paris classification, the pit pattern, and vascular pattern. The simplest, most appropriate and safest endoscopic treatment with curative intent should be selected. For LST-granular homogeneous type, piecemeal endoscopic mucosal resection should be the first option due to its biological low risk of SMI. LST-nongranular pseudodepressed type has an increased risk of SMI, and en bloc resection should be mandatory. Underwater endoscopic mucosal resection is useful in situations where submucosal injection alters the operative field, , for the resection of scar lesions, with no lifting, adjacent tattoo, incomplete resection attempts, lesions into a colonic diverticulum, in ileocecal valve and lesions with intra-appendicular involvement. Endoscopic full thickness resection is very useful for the treatment of difficult to resect lesions of less than 20 up to 25 mm. Among the indications, we highlight the treatment of polyps with suspected malignancy because the acquired tissue allows an exact histologic risk stratification to assign patients individually to the best treatment and avoid surgery for low-risk lesions. Endoscopic submucosal dissection is the only endoscopic procedure that allows completes en bloc resection regardless of the size of the lesion. It should therefore be indicated in the treatment of lesions with risk of SMI.
由于结直肠癌筛查项目的出现以及质量保证结肠镜检查时代的到来,在过去十年中,可被视为困难的息肉数量有所增加,包括大型(> 20 mm)侧向扩散肿瘤(LST)。所有LST均应仔细评估,寻找黏膜下浸润(SMI)的可疑区域,如结节或凹陷区域,并根据巴黎分类、凹陷模式和血管模式描述其形态。应选择最简单、最合适且最安全的具有治愈意图的内镜治疗方法。对于LST颗粒均匀型,由于其SMI的生物学风险较低,内镜下分片黏膜切除术应作为首选。LST非颗粒假凹陷型SMI风险增加,必须进行整块切除。水下内镜黏膜切除术适用于黏膜下注射改变手术视野的情况,用于切除瘢痕病变、无抬举、邻近纹身、不完全切除尝试、进入结肠憩室的病变、回盲瓣病变以及阑尾内受累的病变。内镜全层切除术对于治疗20至25 mm以下难以切除的病变非常有用。在适应证中,我们强调对疑似恶性息肉的治疗,因为获取的组织允许进行精确的组织学风险分层,以便为患者个体分配最佳治疗方案,并避免对低风险病变进行手术。内镜黏膜下剥离术是唯一一种无论病变大小都能进行完整整块切除的内镜手术。因此,它应被用于治疗有SMI风险的病变。